tiprankstipranks
Trending News
More News >
Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market

Dogwood Therapeutics (DWTX) Income Statement

Compare
255 Followers

Dogwood Therapeutics Income Statement

Last quarter (Q3 2025), Dogwood Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Dogwood Therapeutics's net income was $-15.74M. See Dogwood Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -12.18K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 12.23M$ 5.45M$ 12.32M$ 15.64M$ 10.01M
Depreciation and Amortization
$ 12.18K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -12.25M$ -5.45M$ -12.32M$ -15.64M$ -10.01M
Operating Income
$ -12.23M$ -5.45M$ -12.32M$ -15.64M$ -10.01M
Other Income/Expenses
$ -122.98K$ 150.90K$ 67.47K$ -319.33K$ -341.00K
Pretax Income
$ -12.35M$ -5.30M$ -12.25M$ -15.96M$ -10.35M
Net Income
$ -12.35M$ -5.30M$ -12.25M$ -15.96M$ -10.35M
Per Share Metrics
Basic EPS
$ -12.52$ -7.05$ -27.66$ -47.90$ -52.50
Diluted EPS
$ -12.52$ -7.05$ -27.66$ -47.90$ -52.50
Weighted Average Shares Outstanding
1.03M 751.07K 442.80K 333.17K 197.08K
Weighted Average Shares Outstanding (Diluted)
1.03M 751.07K 442.80K 333.17K 197.08K
Currency in USD

Dogwood Therapeutics Earnings and Revenue History